Melanoma brain metastases and vemurafenib: need for further investigation. - Wikidata - awgldk - TriplyDB

Melanoma brain metastases and vemurafenib: need for further investigation.

Melanoma brain metastases and vemurafenib: need for further investigation.

http://www.wikidata.org/entity/Q36512866

about

Molecular interactions in the development of brain metastases Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.Factors influencing the CNS distribution of a novel MEK-1/2 inhibitor: implications for combination therapy for melanoma brain metastases Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib.Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases Cutis verticis gyrata in association with vemurafenib and whole-brain radiotherapy.Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets Targeted therapies in brain metastases.Phase I/II RAF kinase inhibitors in cancer therapy.Biology in prevention and treatment of brain metastases.Dabrafenib therapy for advanced melanoma.Brain metastases: an overview.Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.Oral Targeted Therapies and Central Nervous System (CNS) Metastases.Investigational new drugs for brain cancer.Current treatment options of brain metastases and outcomes in patients with malignant melanoma Challenges in the delivery of therapies to melanoma brain metastases.Molecular subtyping of brain metastases and implications for therapy.LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases.Current and emerging brain applications of MR-guided focused ultrasound.Vemurafenib and radiation therapy in melanoma brain metastases.Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?Primary central nervous system malignant melanoma with leptomeningeal melanomatosis: a case report and review of the literature.Incidence and characteristics of melanoma brain metastases developing during treatment with vemurafenib.Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas.

P2860

Q26865865-C04FE6BD-3AF3-4DBF-894A-3F9BFCC0A3C3 Q33667485-7992DC70-2DAB-44AB-8895-DEC2846BF658 Q33942964-EEC31E1E-A68E-4059-8CC9-165C496F6E0C Q35213142-BDC4D075-BC9C-4E81-B8F1-55314FFE6180 Q36642420-E8EFDB1F-5F0E-4F86-BC03-9F0F6126AA6E Q36934327-7D79ADEA-78AC-4C38-9B52-24B403D02E3F Q37028708-B1508E14-15E3-46A7-AA73-CCFE1BB651AD Q37491460-A11B66D3-159E-4E4D-BBEB-93553A8655FE Q38103961-88690741-CBE2-4785-BF80-2AF2CFDD9F7E Q38156192-3A35A4C2-FCFB-4789-9EB7-1CA4DD7AFC6F Q38164679-DF2CE4CB-8647-49AD-949F-45BB51BA7E04 Q38317417-147E4546-8D15-48FA-8D52-FF936661870D Q38351134-66523D05-029A-469D-9DB3-0C04F47263BD Q38631975-06B796D9-6536-4173-BF69-C5E43A45D116 Q38832510-7F43DEC2-7031-4476-8039-C342A1A9A1C3 Q38948151-3623FD3D-A678-489B-87D5-8FCE5E7C3D5F Q39331752-38D99A74-B3D8-4FE7-A356-45A7AC55D79B Q39373956-E4C48ABC-1E34-4AFE-AF91-72C5F22BC190 Q41677075-FC4D9C2F-0E06-4026-AF34-ADEE43887C55 Q42371224-91EC9937-48A4-4F91-9149-A2D135DD4839 Q44534087-386B2BC4-5D36-41AF-AF6B-1468798B0876 Q47573654-1497489A-7EC9-43E1-8668-9A1C8D55599D Q48030006-FC0EEC93-3859-4F21-B49B-74585728AD95 Q48618698-52E2363B-1378-4FFA-A742-C685650BD404 Q54387586-AC056D9F-C148-487A-A4E4-17F4880B9C32

P2860

Melanoma brain metastases and vemurafenib: need for further investigation.

http://www.wikidata.org/entity/Q36512866

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Melanoma brain metastases and vemurafenib: need for further investigation.

@ast

Melanoma brain metastases and vemurafenib: need for further investigation.

@en

type

label

Melanoma brain metastases and vemurafenib: need for further investigation.

@ast

Melanoma brain metastases and vemurafenib: need for further investigation.

@en

prefLabel

Melanoma brain metastases and vemurafenib: need for further investigation.

@ast

Melanoma brain metastases and vemurafenib: need for further investigation.

@en

P1433

Q36512866-2BE38BC6-EEE2-49C8-976E-05FCFBB44162

P1476

Q36512866-0002FF56-51DB-40E5-A110-644164CFA30B

P2093

Q36512866-09BC24CB-D830-4AD7-B0D7-189CA3D7AEA5

Q36512866-74F1FECC-1029-48EE-B7D6-11FBD4B1143F

Q36512866-9BA58E0C-AC3F-49B2-9C90-4814A79B66C7

Q36512866-A5945A0C-09D9-4737-91C9-6D67F15126A7

Q36512866-BC20409C-8589-48E9-A125-F7FF92547EE1

Q36512866-C4303862-AE6E-4E7A-B9B8-A7837BE5ACF7

Q36512866-F0EB5CAE-7302-4A1D-B7BF-B7B740237FF9

P2860

Q36512866-0BF94FAC-A842-48CA-B08E-99B457046E69

Q36512866-26526BCA-31D6-49F6-9199-3F4BE4F1F3A0

Q36512866-2EDE9368-C251-4A30-8674-85AFBFAE1CE7

Q36512866-477074A7-E65C-4B80-90E8-A1B18BD4E682

Q36512866-5844DCD6-F36C-42EC-A057-B391F9F675F7

Q36512866-686DE11C-8B1B-4B3F-AF83-7C57DD4E43E5

Q36512866-69404C9F-4942-4CB5-AC7D-F68E03832892

Q36512866-C42451AA-A6B7-4568-8219-EF87CF229524

Q36512866-DD582DC7-0FB1-46F6-B547-1BAD8C8DBB28

Q36512866-E3C7BEE6-3DDD-4AB6-99D0-CAA588AA8053

P304

Q36512866-C2E33646-EDDB-45AB-BA7B-D9D45C12947F

P31

Q36512866-99F648EC-CFB4-40E1-8345-3AA8A96FE2A1

P356

Q36512866-1901C096-7302-4E73-89D8-6CCCFAAE1782

P407

Q36512866-FD5E5E5D-FCEC-4609-B113-AD15EBCAC6A2

P433

Q36512866-FC9E7CBF-8D89-4D2A-9F27-C12BD0AC705C

P478

Q36512866-7181EA96-AD20-4342-891B-A070BA0EA570

P577

Q36512866-8C3785B6-1133-4E42-AAB1-AC50E6423B4E

P5875

Q36512866-C048B030-0071-4B01-AD88-CEA01CF21C4A

P698

Q36512866-40CA13B7-9C1F-47A6-ACD6-80D9894C571E

P932

Q36512866-6F102D3F-5EEC-481A-A7DC-151394521416

P356

J.MAYOCP.2012.07.006

P1433

Mayo Clinic Proceedings

P1476

Melanoma brain metastases and vemurafenib: need for further investigation.

@en

P2093

Brian Gorman

http://www.w3.org/2001/XMLSchema#string

Julie R Gilbertson

http://www.w3.org/2001/XMLSchema#string

Lisa A Kottschade

http://www.w3.org/2001/XMLSchema#string

Nicole M Rochet

http://www.w3.org/2001/XMLSchema#string

Rahul N Chavan

http://www.w3.org/2001/XMLSchema#string

Roxana S Dronca

http://www.w3.org/2001/XMLSchema#string

Svetomir N Markovic

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.

Mutations of the BRAF gene in human cancer

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier.

Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma.

Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: vemurafenib (PLX4032)

Determinants of outcome in melanoma patients with cerebral metastases.

Demographics of brain metastasis.

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

P304

976-981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MAYOCP.2012.07.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232086216

http://www.w3.org/2001/XMLSchema#string

P698

23036672

http://www.w3.org/2001/XMLSchema#string

P932

3538399

http://www.w3.org/2001/XMLSchema#string